Solid cancer development in solid organ transplant recipients within the Swiss Transplant Cohort Study.

Lengwiler, Emanuel; Stampf, Susanne; Zippelius, Alfred; Salati, Emanuela; Zaman, Khalil; Schäfer, Niklaus; Schardt, Julian; Siano, Marco; Hofbauer, Günther (2019). Solid cancer development in solid organ transplant recipients within the Swiss Transplant Cohort Study. Swiss medical weekly, 149, w20078. EMH Media 10.4414/smw.2019.20078

[img]
Preview
Text
smw_149_w20078 (1).pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (666kB) | Preview

In solid organ transplant recipients (sOTRs), 5 years after transplantation cancer is a relevant cause of death. We aimed to report cancer incidence in the Swiss Transplant Cohort Study (STCS) between 2008 and 2014 and conducted a prospective cohort study of kidney, heart, lung, pancreas and liver transplant recipients enrolled into the STCS by retrospective analysis of collected data. The STCS provided data on 2758 solid organ transplants. In total, 134 cases of cancer were observed (30 liver, 21 prostate, 18 lung, 13 kidney, 52 other cancers). Standardised incidence ratios (SIRs) were highest for liver cancer, kidney cancer, thyroid cancer, gastric cancer, bladder cancer, cancer of the oral cavity and the pharynx and for lung cancer. Cancer occurrence differed according to the transplanted organ. Cancers were mainly diagnosed at World Health Organisation (WHO) stages I and IV. Treatment received was mainly surgery and, in some cases, included also radiation and/or chemotherapy. Bladder, kidney, liver, lung and prostate cancer were detected at a younger age compared with the general population. Cumulative hazards for death were increased for transplant recipients with cancer. Solid organ transplant recipients show an organ specific increase of cancer compared with the general Swiss population. Clinical trial registration number: NCT02333279.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Schardt, Julian

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1424-3997

Publisher:

EMH Media

Language:

English

Submitter:

Rebeka Gerber

Date Deposited:

03 Dec 2019 13:17

Last Modified:

05 Dec 2022 15:33

Publisher DOI:

10.4414/smw.2019.20078

PubMed ID:

31104307

BORIS DOI:

10.7892/boris.135682

URI:

https://boris.unibe.ch/id/eprint/135682

Actions (login required)

Edit item Edit item
Provide Feedback